Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CORRECTION FROM SOURCE: Response Biomedical Announces Private Placement with Yorkton Securities.


VANCOUVER, British Columbia--(BUSINESS WIRE)--April 15, 1999--

Response Bio(VSE See DOS/VSE.

VSE - Virtual Storage Extended
:RBM RBM Roll Back Malaria (global partnership to reduce malaria)
RBM Results Based Management
RBM Reserve Bank of Malawi
RBM Risk Based Maintenance
RBM Reliability Based Maintenance
RBM Reticular Basement Membrane
RBM Radiation Belt Monitor
.) Response Biomedical bi·o·med·i·cal
adj.
1. Of or relating to biomedicine.

2. Of, relating to, or involving biological, medical, and physical sciences.
 Corp. (RBM.VSE) today announced that Yorkton Securities Inc. is undertaking a brokered private placement of $2,500,000 at $0.95 per share to enable the completion of the commercialization of the RAMP(tm) technology.

"We and our merchant banker, Avenir Capital Corp., are excited to work with a national firm such as Yorkton Securities," said Dr. Harvey Hoyt, Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of Response. "This injection of capital allows Response Biomedical to move RAMP into the manufacturing phase and positions the Company for future sales."

This private placement is subject to the approval of the Vancouver Stock Exchange Vancouver Stock Exchange (VSE)

A securities and options exchange in Vancouver, British Columbia, (Canada), specializing in venture capital companies.


Vancouver Stock Exchange

See Canadian Venture Exchange (CDNX).
. There will be a commission payable to Yorkton Securities Inc.

Response Biomedical Corp. is a health care company focused on the research and commercialization of diagnostic tests for the human health, food safety and environmental markets. The company's website is located at http://www.response-bio.com.

The Vancouver Stock Exchange has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. The statements made in this press release may contain certain forward-looking statements that involve a number of risks and uncertainties. Actual events or results may differ from the company's expectations.

William J. Radvak, President & COO
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1CANA
Date:Apr 16, 1999
Words:217
Previous Article:ACC Issues Modified Recovery Options; Approves Proposed Amendments to Electric Competition Rules.
Next Article:DSI Toys to Receive $5 Million Investment From LLC Controlled by Tom Martin.



Related Articles
Indomin Resources Limited - Brokered Private Placement of Special Warrants.
Xinex Announces Closing of $7 Million Private Placement.
Xinex announces closing of $7 million private placement.
Red Sea Oil Corporation Completes Sale of Private Placement Units.
National Healthcare - Special warrant placement.
Beacon Eye Institute issuing $8 million to $10 million of special warrants -- continuing development of Laser-PRK vision correction.
Response Biomedical Announces Private Placement with Yorkton Securities.
iWave.com Announces Brokered Private Placement With Yorkton Securities Inc. to Raise Gross Proceeds of Up to $2,250,000.
GlobalStore.com, Inc. Formerly Sheffield Resources Inc. Announces Corporate Update.
Caprion Raises Additional $6.2 Million.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles